🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with Familial Adenomatous Polyposis (FAP) who are undergoing endos...
Status
Active Not Recruiting
Location
Michigan Medicine
Start Date
2021-01-18
Trial ID
NCT04230499
Treatments Being Tested
This first-in-human, randomized, double-blind, placebo-controlled, single a...
Status
Not Yet Recruiting
Location
Altasciences Clinical Kansas
Start Date
2026-08-01
Trial ID
NCT06808932
A study to compare the pharmacokinetics and food-effect bioavailability of ...
Status
Completed
Location
ICON
Start Date
2016-11-16
Trial ID
NCT03010631
GSK3039294 has been developed in order to offer an orally available alterna...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-05-12
Trial ID
NCT02603172
Treatments Being Tested
Despite preventive programs, effective case management is still the corners...
Status
Unknown
Location
Department of Pharmacology & Therapeutics, MakCHS, Mulago Hospital Complex
Start Date
2013-09
Trial ID
NCT01944189
Treatments Being Tested
CC-42344 Phase 1 study with single-ascending dose (SAD) and multiple-ascend...
Status
Completed
Location
Linear Clinical Research
Start Date
2022-02-11
Trial ID
NCT05202379
This observational study documents the clinical outcomes of a proprietary, ...
Status
Completed
Location
Zireg
Start Date
2026-01-03
Trial ID
NCT07538661
This is a randomized, double-blind, placebo-controlled phase 1b clinical st...
Status
Not Yet Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-01
Trial ID
NCT07684560
Treatments Being Tested
This is a two part study. The purpose of the first part is primarily to det...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-12
Trial ID
NCT01259882
Treatments Being Tested
To investigate the effect of acid reducing agents (an antacid and an H2-rec...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02097329